# First person – Stephanie May

## TL;DR

Stephanie May discusses her research on a precision model for treating hepatocellular carcinoma using radiotherapy.

## Contribution

The paper introduces a novel precision image-guided model for stereotactic ablative radiotherapy in hepatocellular carcinoma.

## Key findings

- The model aims to improve treatment accuracy for hepatocellular carcinoma.
- It focuses on preventing recurrence and metastasis following radiotherapy.

## Abstract

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Stephanie May is first author on ‘
A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma’, published in DMM. She is a Principal Scientific Officer in the lab of Prof. Tom Bird at the Cancer Research UK Scotland Institute, Glasgow, UK, investigating chemo-preventative therapies for hepatocellular carcinoma (HCC) and the prevention of recurrent/metastatic disease following stereotactic ablative radiotherapy (SABR).